The genotoxicological assessment of a tobacco heating product relative to cigarette smoke using the in vitro micronucleus assay

Toxicology Reports

Volumn 7, Issue , 2020, Pages 1010-1019

  Thorne, David ^a   Whitwell, James ^b   Clements, Julie ^b   Walker, Paul ^c   Breheny, Damien ^a   Gaca, Marianna ^a  

^a BRITISH AMERICAN TOBACCO   (United Kingdom)

^b Department of Genetic and Molecular Toxicology   (United Kingdom)

^c Cyprotex Discovery   (United Kingdom)

Author keywords

CHO; High content screening; In vitro; IVMN; TK6; Tobacco heating product; V79

Indexed keywords

CIGARETTE SMOKE; NICOTINE;

ARTICLE; CELL CULTURE; CELL PROLIFERATION ASSAY; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; FIBROBLAST; GENETIC TRANSFECTION; GENOTOXICITY; HEATING; HUMAN; HUMAN CELL; IN VITRO STUDY; MICRONUCLEUS TEST; PARTICULATE MATTER; PRIORITY JOURNAL; TOBACCO; TREATMENT RESPONSE;

EID: 85089738971     PISSN: 22147500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxrep.2020.08.013     Document Type: Article

References (55)

1. Baker, R.R., Carbonyl compounds in cigarette smoke. Environ. Toxicol. 21 (2006), 621–622 author reply 622.
2. Baker, R.R., Temperature distribution inside a burning cigarette. Nature 247 (1974), 405–406.
3. Fowles, J., Dybing, E., Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke. Tob. Control 12 (2003), 424–430.
4. Hecht, S.S., Cigarette smoking: cancer risks, carcinogens, and mechanisms. Langenbecks Arch. Surg. 391 (2006), 603–613.
5. Rodgman, A., Smith, C.J., Perfetti, T.A., The composition of cigarette smoke: a retrospective, with emphasis on polycyclic components. Hum. Exp. Toxicol. 19 (2000), 573–595.
6. Rodgman, A., Green, C.R., Toxic chemicals in cigarette mainstream smoke - hazard and hoopla. Beitrã¤ge Zur Tab. Int. Tob. Res. 20 (2014), 481–545.
7. Poynton, S., Sutton, J., Goodall, S., Margham, J., Forster, M., Scott, K., Liu, C., Mcadam, K., Murphy, J., Proctor, C., A novel hybrid tobacco product that delivers a tobacco flavour note with vapour aerosol (Part 1): product operation and preliminary aerosol chemistry assessment. Food Chem. Toxicol. 106 (2017), 522–532.
8. Margham, J., Mcadam, K., Forster, M., Liu, C., Wright, C., Mariner, D., Proctor, C., Chemical composition of aerosol from an E-Cigarette: a quantitative comparison with cigarette smoke. Chem. Res. Toxicol. 29 (2016), 1662–1678.
9. Farsalinos, K.E., Yannovits, N., Sarri, T., Voudris, V., Poulas, K., Leischow, S.J., Carbonyl emissions from a novel heated tobacco product (IQOS): comparison with an e-cigarette and a tobacco cigarette. Addiction 113 (2018), 2099–2106.
10. Polosa, R., Farsalinos, K., Prisco, D., Health impact of electronic cigarettes and heated tobacco systems. Intern. Emerg. Med. 14 (2019), 817–820.
11. Schaller, J.P., Keller, D., Poget, L., Pratte, P., Kaelin, E., Mchugh, D., Cudazzo, G., Smart, D., Tricker, A.R., Gautier, L., Yerly, M., Reis Pires, R., Le Bouhellec, S., Ghosh, D., Hofer, I., Garcia, E., Vanscheeuwijck, P., Maeder, S., Evaluation of the Tobacco Heating System 2.2. Part 2: Chemical composition, genotoxicity, cytotoxicity, and physical properties of the aerosol. Regul. Toxicol. Pharmacol. 81:Suppl 2 (2016), S27–S47.
12. Eaton, D., Jakaj, B., Forster, M., Nicol, J., Mavropoulou, E., Scott, K., Liu, C., Mcadam, K., Murphy, J., Proctor, C.J., Assessment of tobacco heating product THP1.0. Part 2: product design, operation and thermophysical characterisation. Regul. Toxicol. Pharmacol. 93 (2018), 4–13.
13. Takahashi, Y., Kanemaru, Y., Fukushima, T., Eguchi, K., Yoshida, S., Miller-Holt, J., Jones, I., Chemical analysis and in vitro toxicological evaluation of aerosol from a novel tobacco vapor product: a comparison with cigarette smoke. Regul. Toxicol. Pharmacol. 92 (2018), 94–103.
14. Crooks, I., Neilson, L., Scott, K., Reynolds, L., Oke, T., Forster, M., Meredith, C., Mcadam, K., Proctor, C., Evaluation of flavourings potentially used in a heated tobacco product: chemical analysis, in vitro mutagenicity, genotoxicity, cytotoxicity and in vitro tumour promoting activity. Food Chem. Toxicol. 118 (2018), 940–952.
15. Forster, M., Fiebelkorn, S., Yurteri, C., Mariner, D., Liu, C., Wright, C., Mcadam, K., Murphy, J., Proctor, C., Assessment of novel tobacco heating product THP1.0. Part 3: comprehensive chemical characterisation of harmful and potentially harmful aerosol emissions. Regul. Toxicol. Pharmacol. 93 (2018), 14–33.
16. Forster, M., Mcaughey, J., Prasad, K., Mavropoulou, E., Proctor, C., Assessment of tobacco heating product THP1.0. Part 4: characterisation of indoor air quality and odour. Regul. Toxicol. Pharmacol. 93 (2018), 34–51.
17. Jaunky, T., Adamson, J., Santopietro, S., Terry, A., Thorne, D., Breheny, D., Proctor, C., Gaca, M., Assessment of tobacco heating product THP1.0. Part 5: in vitro dosimetric and cytotoxic assessment. Regul. Toxicol. Pharmacol. 93 (2018), 52–61.
18. Taylor, M., Thorne, D., Carr, T., Breheny, D., Walker, P., Proctor, C., Gaca, M., Assessment of novel tobacco heating product THP1.0. Part 6: a comparative in vitro study using contemporary screening approaches. Regul. Toxicol. Pharmacol. 93 (2018), 62–70.
19. Thorne, D., Breheny, D., Proctor, C., Gaca, M., Assessment of novel tobacco heating product THP1.0. Part 7: comparative in vitro toxicological evaluation. Regul. Toxicol. Pharmacol. 93 (2018), 71–83.
20. Gee, J., Prasad, K., Slayford, S., Gray, A., Nother, K., Cunningham, A., Mavropoulou, E., Proctor, C., Assessment of tobacco heating product THP1.0. Part 8: study to determine puffing topography, mouth level exposure and consumption among Japanese users. Regul. Toxicol. Pharmacol. 93 (2018), 84–91.
21. Haswell, L.E., Corke, S., Verrastro, I., Baxter, A., Banerjee, A., Adamson, J., Jaunky, T., Proctor, C., Gaca, M., Minet, E., In vitro RNA-seq-based toxicogenomics assessment shows reduced biological effect of tobacco heating products when compared to cigarette smoke. Sci. Rep., 8, 2018, 1145.
22. Gale, N., Mcewan, M., Eldridge, A.C., Fearon, I.M., Sherwood, N., Bowen, E., Mcdermott, S., Holmes, E., Hedge, A., Hossack, S., Wakenshaw, L., Glew, J., Camacho, O.M., Errington, G., Mcaughey, J., Murphy, J., Liu, C., Proctor, C.J., Changes in biomarkers of exposure on switching from a conventional cigarette to tobacco heating products: a randomized, controlled study in healthy japanese subjects. Nicotine Tob. Res. 21 (2019), 1220–1227.
23. Proctor, C., Assessment of tobacco heating product THP1.0. Part 1: series introduction. Regul. Toxicol. Pharmacol. 93 (2018), 1–3.
24. (Nrc), N. R. C, Toxicity Testing in the 21st Century: A Vision and a Strategy. 2007, The National Academies Press, Washington, DC.
25. Kavlock, R., Chandler, K., Houck, K., Hunter, S., Judson, R., Kleinstreuer, N., Knudsen, T., Martin, M., Padilla, S., Reif, D., Richard, A., Rotroff, D., Sipes, N., Dix, D., Update on EPA's ToxCast program: providing high throughput decision support tools for chemical risk management. Chem. Res. Toxicol. 25 (2012), 1287–1302.
26. Thorne, D., Hollings, M., Seymour, A., Adamson, J., Dalrymple, A., Ballantyne, M., Gaca, M., Extreme testing of undiluted e-cigarette aerosol in vitro using an Ames air-agar-interface technique. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 828 (2018), 46–54.
27. Adamson, J., Jaunky, T., Thorne, D., Gaca, M.D., Characterisation of the borgwaldt LM4E system for in vitro exposures to undiluted aerosols from next generation tobacco and nicotine products (NGPs). Food Chem. Toxicol. 113 (2018), 337–344.
28. Iskandar, A.R., Gonzalez-Suarez, I., Majeed, S., Marescotti, D., Sewer, A., Xiang, Y., Leroy, P., Guedj, E., Mathis, C., Schaller, J.P., Vanscheeuwijck, P., Frentzel, S., Martin, F., Ivanov, N.V., Peitsch, M.C., Hoeng, J., A framework for in vitro systems toxicology assessment of e-liquids. Toxicol. Mech. Methods 26 (2016), 389–413.
29. Iskandar, A.R., Zanetti, F., Marescotti, D., Titz, B., Sewer, A., Kondylis, A., Leroy, P., Belcastro, V., Torres, L.O., Acali, S., Majeed, S., Steiner, S., Trivedi, K., Guedj, E., Merg, C., Schneider, T., Frentzel, S., Martin, F., Ivanov, N.V., Peitsch, M.C., Hoeng, J., Application of a multi-layer systems toxicology framework for in vitro assessment of the biological effects of Classic Tobacco e-liquid and its corresponding aerosol using an e-cigarette device with MESH technology. Arch. Toxicol., 2019.
30. Clippinger, A.J., Allen, D., Behrsing, H., Berube, K.A., Bolger, M.B., Casey, W., Delorme, M., Gaca, M., Gehen, S.C., Glover, K., Hayden, P., Hinderliter, P., Hotchkiss, J.A., Iskandar, A., Keyser, B., Luettich, K., Ma-Hock, L., Maione, A.G., Makena, P., Melbourne, J., Milchak, L., Ng, S.P., Paini, A., Page, K., Patlewicz, G., Prieto, P., Raabe, H., Reinke, E.N., Roper, C., Rose, J., Sharma, M., Spoo, W., Thorne, P.S., Wilson, D.M., Jarabek, A.M., Pathway-based predictive approaches for non-animal assessment of acute inhalation toxicity. Toxicol. In Vitro 52 (2018), 131–145.
31. Murphy, J., Liu, C., Mcadam, K., Gaa, M., Prasad, K., Camacho, O., Mcaughey, J., Proctor, C., Assessment of tobacco heating product THP1.0. Part 9: the placement of a range of next-generation products on an emissions continuum relative to cigarettes via pre-clinical assessment studies. Regul. Toxicol. Pharmacol. 93 (2018), 92–104.
32. Coresta, The Rationale and Strategy for Conducting in Vitro Toxicological Testing of Tobacco Smoke. 2004.
33. Canada, H., Health Canada, Tobacco Reporting Regulations., 2005.
34. Com, Committee on mutagenicity of chemicals in food, consumer products and the environment. Guidance on a Strategy for Genotoxicity Testing of Chemical Substances, 2011.
35. Oecd, Test No. 487: In Vitro Mammalian Cell Micronucleus Test. 2016.
36. Aardema, M.J., Snyder, R.D., Spicer, C., Divi, K., Morita, T., Mauthe, R.J., Gibson, D.P., Soelter, S., Curry, P.T., Thybaud, V., Lorenzon, G., Marzin, D., Lorge, E., SFTG international collaborative study on in vitro micronucleus test: III. Using CHO cells. Mutat. Res. Toxicol. Environ. Mutagen. 607 (2006), 61–87.
37. Kirkland, D., SFTG international collaborative study on in vitro micronucleus test. Mutat. Res. Toxicol. Environ. Mutagen., 607, 2006, 1.
38. Clare, M.G., Lorenzon, G., Akhurst, L.C., Marzin, D., Van Delft, J., Montero, R., Botta, A., Bertens, A., Cinelli, S., Thybaud, V., Lorge, E., SFTG international collaborative study on in vitro micronucleus test: II. Using human lymphocytes. Mutat. Res. Toxicol. Environ. Mutagen. 607 (2006), 37–60.
39. Wakata, A., Matsuoka, A., Yamakage, K., Yoshida, J., Kubo, K., Kobayashi, K., Senjyu, N., Itoh, S., Miyajima, H., Hamada, S., Nishida, S., Araki, H., Yamamura, E., Matsui, A., Thybaud, V., Lorenzon, G., Marzin, D., Lorge, E., SFTG international collaborative study on in vitro micronucleus test: IV. Using CHL cells. Mutat. Res. Toxicol. Environ. Mutagen. 607 (2006), 88–124.
40. Thorne, D., Leverette, R., Breheny, D., Lloyd, M., Mcenaney, S., Whitwell, J., Clements, J., Bombick, B., Gaca, M., Genotoxicity evaluation of tobacco and nicotine delivery products: part two. In vitro micronucleus assay. Food Chem. Toxicol., 132, 2019, 110546.
41. Canada, H., Health Canada Official Method T-115. Determination of “tar”, Nicotine and Carbon Monoxide in Mainstream Tobacco Smoke. 1999.
42. Fenech, M., Bonassi, S., Turner, J., Lando, C., Ceppi, M., Chang, W.P., Holland, N., Kirsch-Volders, M., Zeiger, E., Bigatti, M.P., Bolognesi, C., Cao, J., De Luca, G., Di Giorgio, M., Ferguson, L.R., Fucic, A., Lima, O.G., Hadjidekova, V.V., Hrelia, P., Jaworska, A., Joksic, G., Krishnaja, A.P., Lee, T.K., Martelli, A., Mckay, M.J., Migliore, L., Mirkova, E., Muller, W.U., Odagiri, Y., Orsiere, T., Scarfi, M.R., Silva, M.J., Sofuni, T., Surralles, J., Trenta, G., Vorobtsova, I., Vral, A., Zijno, A., Project, H.U.M., Intra- and inter-laboratory variation in the scoring of micronuclei and nucleoplasmic bridges in binucleated human lymphocytes. Results of an international slide-scoring exercise by the HUMN project. Mutat. Res. 534 (2003), 45–64.
43. Kirkland, D.J., Statistical evaluation of mutagenicity test data: recommendations of the U.K. Environmental Mutagen Society. Environ. Health Perspect. 102:Suppl 1 (1994), 43–47.
44. Diaz, D., Scott, A., Carmichael, P., Shi, W., Costales, C., Evaluation of an automated in vitro micronucleus assay in CHO-K1 cells. Mutat. Res. 630 (2007), 1–13.
45. Thorne, D., Leverette, R., Breheny, D., Lloyd, M., Mcenaney, S., Whitwell, J., Clements, J., Bombick, B., Gaca, M., Genotoxicity evaluation of tobacco and nicotine delivery products: part one. Mouse lymphoma assay. Food Chem. Toxicol., 132, 2019, 110584.
46. Whitwell, J., Smith, R., Chirom, T., Watters, G., Hargreaves, V., Lloyd, M., Phillips, S., Clements, J., Inclusion of an extended treatment with recovery improves the results for the human peripheral blood lymphocyte micronucleus assay. Mutagenesis, 2019.
47. Lukamowicz, M., Woodward, K., Kirsch-Volders, M., Suter, W., Elhajouji, A., A flow cytometry based in vitro micronucleus assay in TK6 cells—validation using early stage pharmaceutical development compounds. Environ. Mol. Mutagen. 52 (2011), 363–372.
48. Nicolette, J., Diehl, M., Sonders, P., Bryce, S., Blomme, E., In vitro micronucleus screening of pharmaceutical candidates by flow cytometry in Chinese hamster V79 cells. Environ. Mol. Mutagen. 52 (2011), 355–362.
49. Shi, J., Bezabhie, R., Szkudlinska, A., Further evaluation of a flow cytometric in vitro micronucleus assay in CHO-K1 cells: a reliable platform that detects micronuclei and discriminates apoptotic bodies. Mutagenesis 25 (2009), 33–40.
50. Roemer, E., Zenzen, V., Conroy, L.L., Luedemann, K., Dempsey, R., Schunck, C., Sticken, E.T., Automation of the in vitro micronucleus and chromosome aberration assay for the assessment of the genotoxicity of the particulate and gas-vapor phase of cigarette smoke. Toxicol. Mech. Methods 25 (2015), 320–333.
51. Massey, E., Aufderheide, M., Koch, W., Lodding, H., Pohlmann, G., Windt, H., Jarck, P., Knebel, J.W., Micronucleus induction in V79 cells after direct exposure to whole cigarette smoke. Mutagenesis 13 (1998), 145–149.
52. Okuwa, K., Tanaka, M., Fukano, Y., Nara, H., Nishijima, Y., Nishino, T., In vitro micronucleus assay for cigarette smoke using a whole smoke exposure system: a comparison of smoking regimens. Exp. Toxicol. Pathol. 62 (2010), 433–440.
53. Bryce, S., Bernacki, D., Bemis, J., Spellman, R., Engel, M., Schuler, M., Lorge, E., Heikkinen, P., Hemmann, U., Thybaud, V., Wilde, S., Queisser, N., Sutter, A., Zeller, A., Guérard, M., Kirkland, D., Dertinger, S., Interlaboratory evaluation of a multiplexed high information content in vitro genotoxicity assay. Environ. Mol. Mutagen. 58 (2017), 146–161.
54. Hendriks, G., Derr, R.S., Misovic, B., Morolli, B., Calléja, F.M.G.R., Vrieling, H., The extended ToxTracker assay discriminates between induction of DNA damage, oxidative stress, and protein misfolding. Toxicol. Sci. 150 (2015), 190–203.
55. Roemer, E., Mainstream smoke chemistry and in vitro and in vivo toxicity of the reference cigarettes 3R4F and 2R4F. Beitrã¤ge Zur Tab. Int. Tob. Res. 25 (2014), 316–335.